Retraction to: Cancer Gene Therapy https://doi.org/10.1038/s41417-022-00459-0, published online 30 March 2022
The Editor-in-Chief has retracted this article. After publication irregularities were noted in multiple figures, specifically:
In Figure 2E there is overlap between the images in the 2% CSE for A549 and HCI-N292.
Figure 4F the Rac1 band overlaps with the CREB band in figure 5C.
Furthermore, the authors were unable to provide the raw images of the blots published in this study. the The Editor-in-Chief has therefore lost confidence in the results presented in this article.
Yichu Nie does not agree to this retraction. Fenglan Feng, Wei Luo, Andrew J. Sanders, Yidi Zhang, Jiaming Liang, Cheng Chen, Weineng Feng, Weiquan Gu, Weiping Liao, Wei Wang, Jinfeng Chen, Lijian Zhang, Wen G. Jiang and Jin Li have not responded to any correspondence from the editor about this retraction.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Nie, Y., Feng, F., Luo, W. et al. Retraction Note: Overexpressed transient receptor potential vanilloid 1 (TRPV1) in lung adenocarcinoma harbours a new opportunity for therapeutic targeting. Cancer Gene Ther 30, 1583 (2023). https://doi.org/10.1038/s41417-023-00677-0
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41417-023-00677-0
